Dissolution Testing for Bioavailability of Over-the-Counter (OTC) Drugs—a Technical Note
Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 5
Abstract
Thermoforma Orbital Shaker (420-4, Waltham, MA) was used to shake sample solutions at 100 RPM and 37°C. Orion pH Meter (710-1, Pittsburgh, PA) was used to measure solution pH. Two-point calibration with pH reference solution was performed before use of the pH meter. A Distek dissolution apparatus (2100A-2, North Brunswick, NJ) was used to conduct dissolution testing. For dissolution methods that require UV-Vis as the determinative step, an Agilent UV-Vis Spectrophotometer (8453-1, Santa Clara, CA) was used. For dissolution methods that require HPLC, an Agilent 1290 HPLC system with DAD detector was used.
Authors and Affiliations
Zongming Gao, Lawrence Yu, Stephanie Clark, Mike Trehy, Terry Moore, Benjamin Westenberger, Lucinda Buhse, John Kauffman, Benjamin Bishop, Lydia Velazquez, Scott Furness
Keywords
Related Articles
- EP ID EP682321
- DOI 10.1208/s12249-015-0297-x
- Views 74
- Downloads 0
A Non-invasive Method for the Determination of Liquid Injectables by Raman Spectroscopy
The online version of this article (doi:10.1208/s12249-015-0286-0) contains supplementary material, which is available to authorized users.
Finite Element Method (FEM) Modeling of Freeze-drying: Monitoring Pharmaceutical Product Robustness During Lyophilization
Lyophilization is an approach commonly undertaken to formulate drugs that are unstable to be commercialized as ready to use (RTU) solutions. One of the important aspects of commercializing a lyophilized product is to tra...
Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects
Monoclonal antibody biotherapeutics are often administered by subcutaneous (SC) injection. Due to dose requirements and formulation limitations, SC injections >1 mL are often required. We used a viscous p...
Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale
The objective of the study was to develop an amorphous solid dispersion (ASD) for an insoluble compound X by hot melt extrusion (HME) process. The focus was to identify material-sparing approaches to develop bioavailable...
Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations
The online version of this article (doi:10.1208/s12249-015-0299-8) contains supplementary material, which is available to authorized users.